Zvonimir Misir

Zvonimir Misir

Auto-generated profile, based on publicly available information

Zvonimir Misir

Department of Upper Gastrointestinal Surgery, Sestre milosrdnice University Hospital Center, Zagreb, Croatia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2019 in Hernia
Verified
Journal Article
Closed access
PDF file
JFJ. Filipović-Čugura
J. Filipović-Čugura
ZMZ. Misir
Z. Misir
PHP. Hrabač
P. Hrabač
TOT. Orešić
T. Orešić
DVD. Vidović
D. Vidović
AMA. Mijić
A. Mijić

1 March 2013
Verified
Journal Article
Closed access
AMAljosa Matejcić
Aljosa Matejcić
DVDinko Vidović
Dinko Vidović
MIMihovil Ivica
Mihovil Ivica
DDDragan Durdević
Dragan Durdević
MTMladen Tomljenović
Mladen Tomljenović
ZMZvonimir Misir
Zvonimir Misir

28 December 2023 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
ZMZvonimir Misir
Zvonimir Misir
GGGoran Glavčić
Goran Glavčić
SJSuzana Janković
Suzana Janković
IKIvan Kruljac
Ivan Kruljac
JFJakša Čugura Filipović
Jakša Čugura Filipović
MUMonika Ulamec
Monika Ulamec
Gastric cancer (GC) is one of the most common malignancies worldwide and the fourth leading cause of cancer-related deaths. GC is a multifactorial disease influenced by both environmental and genetic factors. Its most critical features include invasiveness and high metastatic potential. Metastasis is a complex process, and our understanding of the mechanisms involved remains incomplete. Growing evidence suggests that cancer-testis antigens (CTAs) play a crucial role in the metastatic potential of various tumors. Several studies have linked CTA expression with lower tumor differentiation, higher metastatic potential, and poor chemotherapy response. New York esophageal squamous cell carcinoma-1 (NY-ESO-1) antigen, part of the CTA group, is expressed in tumor tissues, while its expression in normal tissues is restricted to spermatogonia. This study aimed to determine the expression of NY-ESO-1 in primary adenocarcinoma of the stomach, both with and without metastasis in regional lymph nodes, and to compare it with TNM stage, age, gender, and survival. We analyzed GC tissue from 53 node-negative and 55 node-positive primary gastric carcinoma patients for NY-ESO-1 expression using immunohistochemical assay. The results were correlated with clinicopathological parameters and survival. Patients with positive NY-ESO-1 expression in primary tumors had a median survival of 19.0 months (range 14.1–24.0), in contrast to those with negative expression, who had a median survival of 52.0 months (range 0.0–133.3) (chi-square 7.99, P=0.005). T status, N status, and NY-ESO-1 expression were all independently associated with shorter survival. No significant difference in NY-ESO-1 expression in primary tumors was observed concerning lymph node metastasis status. In summary, our findings suggest that increased expression of NY-ESO-1 could potentially serve as a prognostic biomarker for GC.

30 November 2024 in Pancreatology
Verified
Journal Article
Closed access
NBNina Blazevic
Nina Blazevic
Vladimir TrkuljaVladimir Trkulja
Vladimir Trkulja
DRDunja Rogic
Dunja Rogic
SPStipe Pelajić
Stipe Pelajić
MMMarijana Miler
Marijana Miler
TPTajana Pavic
Tajana Pavic

1 January 2019 in Libri Oncologici : Croatian Journal of Oncology
Verified
Journal Article
Open access
PDF file
IKIva Kirac
Iva Kirac
JFJana Fila
Jana Fila
ZMZvonimir Misir
Zvonimir Misir
JČJakša Filipović Čugura
Jakša Filipović Čugura
AŽAna Žaja
Ana Žaja
LŠLjilja Štefančić
Ljilja Štefančić
Gastric cancer is a ‘neglected cancer,’ with significant incidence (over 900 cases annually) and late-stage at the time of diagnosis in Croatia. Even in resectable cases, risk of malnutrition is high, and malnutrition-related to...

1 March 2013
Verified
Journal Article
Closed access
DVDinko Vidović
Dinko Vidović
AMAljosa Matejcić
Aljosa Matejcić
MIMihovil Ivica
Mihovil Ivica
DDDragan Durdević
Dragan Durdević
MTMladen Tomljenović
Mladen Tomljenović
ZMZvonimir Misir
Zvonimir Misir